See their community guidelines here: https://bit.ly/3Bs17Ra
CSL
Founded 1916
Melbourne, Australia
23077 employees
Post-IPO Equity
Total: $111.00M
Biotechnology, Health Care
Melbourne, Australia
23077 employees
Post-IPO Equity
Total: $111.00M
Biotechnology, Health Care
General Information
Company Name
CSL
Founded Year
1916
Location
Melbourne, Australia
Melbourne, Australia
Founders / Decision Makers
Employees
23077
Industries
Biotechnology, Health Care
Funding Stage
Post-IPO Equity
Offices
as of Aug 2026
AU Victoria Melbourne 3000, AU Victoria Melbourne 3000
US PA King of Prussia 19406, US PA King of Prussia 19406
BounceWatch is an independent company data service, not affiliated with CSL. To contact CSL, visit csl.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does CSL compare?
A PDF of CSL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting CSL soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Australia Market
Biotechnology
About CSL
Business keywords: lifesaving medicines, haemophilia treatment, immune deficiencies treatment, vaccines, influenza prevention, iron deficiency therapies, dialysis treatments, nephrology treatments, global reach, commercial strength, R&D focus, operational excellence, innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $111.00M | - |
|
06 Feb 2004 |
CSL Alternatives & Competitors
View All Alternatives
CSL vs
Mazen Animal Health - Oral Vaccines
United States
Game-changing animal disease prevention with orally-delivered, RT stable, cost effective vaccines fo...
Series A
21 employees
Biotechnology, Health Care
CSL vs
The Care Continues...
9205 employees
Biotechnology, Health Care
CSL vs
Elanco
United States
Making life better for animals, makes life better.
IPO
9331 employees
Biotechnology, Health Care
FAQ About CSL
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr...
CSL was founded in 1916.
CSL is headquartered in Melbourne, Australia. As of Aug 2026, it also has offices in AU Victoria Melbourne 3000, AU Victoria Melbourne 3000 and US PA King of Prussia 19406, US PA King of Prussia 19406.
CSL operates in Biotechnology and Health Care. Its work centres on lifesaving medicines, haemophilia treatment, immune deficiencies treatment and vaccines.
CSL has approximately 23077 employees.
CSL has completed 1 funding round, raising a total of $111.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to CSL include Mazen Animal Health - Oral Vaccines, Cadila Pharmaceuticals Limited, Elanco, MSN Laboratories, BIOTRONIK. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CSL and Mazen Animal Health - Oral Vaccines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for CSL, https://bouncewatch.com/company/csl, updated 6 August 2026. When citing, please name BounceWatch and link this page.
